Elevance Health Inc. (ELV) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-01-27 (expected, before the open). EPS estimate 2.08, revenue estimate 49.38B.
Over the last 12 reports the stock moved 7.1% on average (either way), rising 7 times and falling 5. EPS beat estimates 10 of 12 times; revenue 11 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-21 | 6.99 | 4.71 | +48.4% | 50.44B | 49.28B | +1.2% |
| Q2 FY2026 | 2026-07-15 | 7.45 | 6.21 | +20.0% | 49.83B | 48.88B | -12.6% |
| Q1 FY2026 | 2026-04-22 | 12.58 | 10.82 | +16.3% | 49.49B | 48.20B | +5.5% |
| Q4 FY2025 | 2026-01-28 | 3.33 | 3.10 | +7.4% | 49.31B | 49.84B | +7.5% |
| Q3 FY2025 | 2025-10-21 | 6.03 | 4.93 | +22.3% | 50.09B | 49.38B | -2.5% |
| Q2 FY2025 | 2025-07-17 | 8.84 | 8.91 | -0.8% | 49.42B | 48.19B | -19.6% |
| Q1 FY2025 | 2025-04-22 | 11.97 | 11.41 | +4.9% | 48.77B | 46.30B | +5.0% |
| Q4 FY2024 | 2025-01-23 | 3.84 | 3.80 | +1.1% | 45.44B | 44.95B | +2.6% |